Table 1.
Baseline Clinical Characteristics of 122 Patients Who Had Thyroid Function Reassessed
| Characteristic | Value |
|---|---|
| Age, yr | 58 (44–63) |
|
| |
| Male sex | 60 (49.2) |
|
| |
| Smoking | 19/105 (18.1) |
|
| |
| Drinking | 22/102 (21.6) |
|
| |
| Abnormal TFTs on admission | 20 (16.4) |
|
| |
| Baseline anti-TPO positivity | 25 (20.5) |
|
| |
| Baseline anti-Tg positivity | 13 (10.7) |
|
| |
| Baseline COVID-19 severity | |
| Mild | 99 (81.1) |
| Moderate | 19 (15.6) |
| Severe | 4 (3.3) |
|
| |
| Baseline CRP, mg/dL | 0.69 (0.31–2.21) |
|
| |
| Baseline ESR, mm/hr | 40 (24–65) |
|
| |
| Comorbidities | |
| Hypertension | 29 (23.8) |
| Diabetes mellitus | 19 (15.6) |
| CAD or heart failure | 4 (3.3) |
| Stroke or TIA | 3 (2.5) |
| Malignancy | 5 (4.1) |
| Pulmonary disease | 3 (2.5) |
|
| |
| Clinical course | |
| Length of hospitalization, day | 8 (6–11) |
| Interferon beta-1b treatment | 91 (74.6) |
| Dexamethasone requirement | 15 (12.3) |
| Oxygen requirement | 12 (9.8) |
| Intensive care unit admission | 2 (1.6) |
Values are expressed as median (interquartile range) or number (%).
TFT, thyroid function test; TPO, thyroid peroxidase antibody; Tg, thyroglobulin; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; CAD, coronary artery disease; TIA, transient ischemic attack.